Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2

NCT03548779 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT03548779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03548779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Not applicable
Overall status
Completed
Start date
September 28, 2018
Completion date
September 8, 2024
Enrollment
548 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, brain malformation, chromosome abnormality, congenital abnormality, development delay, dysmorphic features, epilepsy; seizure, genetic disease, hearing loss, hypotonia, inborn errors of metabolism, intellectual disability, macrocephaly, microcephaly, movement disorders, neuromuscular diseases, skeletal dysplasia